Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlobalData Plc
  6. News
  7. Summary
    DATA   GB00B87ZTG26


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GlobalData : Japan to account for about 25% of Asia-Pacific thyroid function tests market, forecasts GlobalData

10/14/2021 | 12:12am EST
14 Oct 2021
Japan to account for about 25% of Asia-Pacific thyroid function tests market, forecasts GlobalData
Posted in Medical Devices

Japan is expected to account for about 25% of the total Asia-Pacific (APAC) thyroid function tests (TSH) market in 2021, driven by aging population and significantly better healthcare system compared to other large economies, forecasts GlobalData, a leading data, and analytics company.

GlobalData's latest report, 'Thyroid Function Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)', reveals that Beckman Coulter, Inc., Roche Diagnostics International Ltd, Siemens Healthineers AG, Abbott Laboratories and Ortho Clinical Diagnostics Inc. are the leading players in Japan, accounting for more than 80% of the thyroid function tests market in Japan in 2021.

Minith Kumar, Medical Devices Analyst at GlobalData, comments: "Japan has significantly higher number of patients suffering from hyperthyroidism and hypothyroidism due to its aging population. There is a diverse difference in the prevalence and incidence of thyroid disease based on age and gender. Specifically, hyperthyroidism and hypothyroidism are more common in the elderly and women. Thyroid disease affects five to ten times more females than males, with the highest prevalence being observed in the aged population."

Thyroid stimulation hormone (TSH) is the most performed thyroid function test in Japan and it is set to account for about 65% of the total market in 2021.

Mr. Kumar concludes: "The thyroid function tests market is expected to witness steady growth in the next five years due to the prevailing better healthcare system in Japan where focus is on both diagnosis and monitoring of diseases. Japan not only has a significant percentage of population in the higher aged group compared to other developed economies but also a fast-aging population. Although this is expected to lead to higher test volumes in the future, competitive pricing pressures on medical devices and services may counteract market growth in terms of value."


GlobalData plc published this content on 14 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 October 2021 04:11:03 UTC.

ę Publicnow 2021
All news about GLOBALDATA PLC
11/29GlobalData reveals top 10 most mentioned airline operators on social media in 2021
11/23Amazon's Visa block called out as tactic to promote Mastercard
11/18GLOBALDATA : Global deal activity down by 5.7% in October 2021, finds GlobalData
11/18GLOBALDATA : AMETEK's job adverts double in 2021 as it prepares to expand into new markets..
11/18Slovenia could become the adventure tourism capital of Europe, says GlobalData
11/18GLOBALDATA : Thailand's hot drinks sector to reach US$2.2bn by 2025, says GlobalData
11/18GLOBALDATA : South Korean hot drinks market to reach US$3bn by 2025, forecasts GlobalData
11/18GLOBALDATA : Hot drinks sector of Philippines to reach US$2.4bn by 2025, forecasts GlobalD..
11/18GLOBALDATA : Psilocybin has potential to become a breakthrough therapy for treatment-resis..
11/18GLOBALDATA : Hot drinks market of Malaysia to reach US$2bn by 2025, says GlobalData
More news
Sales 2021 190 M 251 M 251 M
Net income 2021 26,3 M 34,8 M 34,8 M
Net Debt 2021 64,8 M 85,7 M 85,7 M
P/E ratio 2021 70,4x
Yield 2021 1,37%
Capitalization 1 640 M 2 168 M 2 169 M
EV / Sales 2021 8,98x
EV / Sales 2022 8,24x
Nbr of Employees 3 472
Free-Float 30,8%
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 4
Last Close Price 1 390,00 GBX
Average target price 1 735,00 GBX
Spread / Average Target 24,8%
EPS Revisions
Managers and Directors
Michael Thomas Danson Chief Executive Officer & Director
Sally Kate Miranda Johnson Chief Financial Officer
Murray Legg Independent Non-Executive Chairman
Peter Martin Harkness Independent Non-Executive Director
Catherine Birkett Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
S&P GLOBAL INC.36.60%109 796
RELX PLC30.77%59 771
MSCI INC.35.14%49 752
EQUIFAX INC.46.49%34 465